246 related articles for article (PubMed ID: 24587336)
21. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice.
Boshoff C; Gao SJ; Healy LE; Matthews S; Thomas AJ; Coignet L; Warnke RA; Strauchen JA; Matutes E; Kamel OW; Moore PS; Weiss RA; Chang Y
Blood; 1998 Mar; 91(5):1671-9. PubMed ID: 9473233
[TBL] [Abstract][Full Text] [Related]
22. Viral, immunologic, and clinical features of primary effusion lymphoma.
Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS
Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B
J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578
[TBL] [Abstract][Full Text] [Related]
24. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.
Lefort S; Flamand L
J Virol; 2009 Jun; 83(11):5869-80. PubMed ID: 19321621
[TBL] [Abstract][Full Text] [Related]
26. Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy.
Sakamoto T; Ajiro M; Watanabe A; Matsushima S; Ueda K; Hagiwara M
BMC Cancer; 2023 Jan; 23(1):71. PubMed ID: 36670405
[TBL] [Abstract][Full Text] [Related]
27. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
28. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
Haddad L; El Hajj H; Abou-Merhi R; Kfoury Y; Mahieux R; El-Sabban M; Bazarbachi A
Leukemia; 2008 Apr; 22(4):826-34. PubMed ID: 18094712
[TBL] [Abstract][Full Text] [Related]
29. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
30. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
31. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.
Carbone A; Cesarman E; Gloghini A; Drexler HG
AIDS; 2010 Feb; 24(4):479-90. PubMed ID: 20051807
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
[TBL] [Abstract][Full Text] [Related]
33. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
35. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.
Wies E; Mori Y; Hahn A; Kremmer E; Stürzl M; Fleckenstein B; Neipel F
Blood; 2008 Jan; 111(1):320-7. PubMed ID: 17890449
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
37. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
Wu W; Rochford R; Toomey L; Harrington W; Feuer G
Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
